Back to the Top
The following message was posted to: PharmPK
Has anybody got clinical (or "pharmacokinetical") experience with
amikacin (once daily
dose = ODD) in pediatric cystic fibrosis (CF) patients?
With our data (and some other studies) I think that this sort of
scheme is not well
documented, but I'd like to know if somebody have personal experience
ODD (or perhaps twice daily) amikacin in CF.
I know that several (only few) groups have been working with that
nowadays, I have not found ACTUALIZED assays.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (firstname.lastname@example.org)